MEDD (Medical Imaging) EBITDA Margin %: 2.89% (As of Sep. 2018)


What is Medical Imaging EBITDA Margin %?

Medical Imaging MEDD EBITDA Margin % is 2.89% as of Sep. 2018.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medical Imaging's EBITDA for the three months ended in Sep. 2018 was $0.04 Mil. Medical Imaging's Revenue for the three months ended in Sep. 2018 was $1.39 Mil. Therefore, Medical Imaging's EBITDA margin for the quarter that ended in Sep. 2018 was 2.89%.

Medical Imaging  (OTCPK:MEDD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Medical Imaging EBITDA Margin % Related Terms

Medical Imaging EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medical Imaging's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Imaging EBITDA Margin % Chart

Medical Imaging Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.46 7.70 -9.83 -3.87 -25.91

Medical Imaging Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.55 -54.77 -6.66 13.23 2.89

MEDD vs TEAR, INVB, DCTH: EBITDA Margin % Comparison

For the Diagnostics & Research subindustry, Medical Imaging's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medical Imaging EBITDA Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medical Imaging's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medical Imaging's EBITDA Margin % falls into.


Medical Imaging EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medical Imaging's EBITDA Margin % for the fiscal year that ended in Dec. 2017 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-1.872/7.224
=-25.91 %

Medical Imaging's EBITDA Margin % for the quarter that ended in Sep. 2018 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2018 )/Revenue (Q: Sep. 2018 )
=0.04/1.385
=2.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 2.89% mean?
Medical Imaging (MEDD) has a EBITDA Margin % of 2.89% as of Sep. 2018. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Imaging and its competitors.
Is Medical Imaging's EBITDA Margin % too high?
Medical Imaging's current EBITDA Margin % is 2.89%. The Medical Diagnostics & Research industry median EBITDA Margin % is 5.00. Medical Imaging's value of 2.89% is 42.2% below this industry median.
How does Medical Imaging's EBITDA Margin % compare to TEAR and INVB?
Medical Imaging's EBITDA Margin % of 2.89% can be compared against companies in the Medical Diagnostics & Research industry. The industry median EBITDA Margin % is 5.00. Medical Imaging's value of 2.89% is 42.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Diagnostics & Research company?
The median EBITDA Margin % among Medical Diagnostics & Research companies is 5.00, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current EBITDA Margin % of 2.89% is 42.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Imaging and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA Margin % is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current EBITDA Margin % is 2.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Medical Imaging (MEDD) has a current EBITDA Margin % of 2.89%. The current EBITDA Margin % is 2.89% and 42.2% below the Medical Diagnostics & Research industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medical Imaging (MEDD), the current EBITDA Margin % is 2.89% as of Sep. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Imaging Business Description

Address 848 N Rainbow Boulevard, No. 2494, Las Vegas, NV, USA, 89107
Medical Imaging Corp is a United States-based healthcare services company focused on the acquisition of existing full-service imaging clinics. Through its subsidiaries, the firm provides medical diagnostic imaging services. The services provided include magnetic resonance imaging, CT scans, ultrasound, X-ray, and others. The group has operations in the United States and Canada. The organization generates revenue from the medical scans services and teleradiology services, of which medical scans services contributes the maximum to the revenue.